Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€76.71

€76.71

-0.510%
-0.39
-0.510%
€94.89
 
11.06.25 / Tradegate WKN: A14M2J / Symbol: MDT / Name: Medtronic / Stock / Healthcare Equipment & Supplies / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15JS chart by amCharts
Select a timeframe to show chart data
From: to:
Zoom:
Your prediction

Medtronic plc Stock

The price for the Medtronic plc stock decreased slightly today. Compared to yesterday there is a change of -€0.390 (-0.510%).
With 12 Buy predictions and not the single Sell prediction the community is currently very high on Medtronic plc.
As a result the target price of 94 € shows a positive potential of 22.54% compared to the current price of 76.71 € for Medtronic plc.
For the coming years our community has positive and negative things to say abot the Medtronic plc stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "General Risks" there were negative voices in the community.

Pros and Cons of Medtronic plc in the next few years

Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
C******** o* t** e**********
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Medtronic plc vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Medtronic plc -0.510% 2.253% 3.466% 0.524% -0.441% -12.988% -4.590%
Henry Schein Inc. 0.610% 1.297% 2.426% 0.904% -6.355% -19.287% 26.363%
Teleflex Inc. -2.780% 0.000% -4.545% -45.313% -37.500% -58.333% -66.346%
Baxter International -1.570% 4.112% -1.654% -10.696% -1.743% -60.672% -63.032%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-04-19

Upon first glance at Medtronic's financials, the company appears to be a strong player in the Healthcare Equipment & Supplies sector. Over the years, Medtronic has demonstrated relatively stable financial performance, which is a desirable attribute for a healthcare company. However, more in-depth analysis is needed to better understand the pros and cons of its financial situation.

Revenue Growth: Medtronic's total revenue has experienced consistent growth over the last three years as seen in the yearly income statements. In 2020, the company recorded total revenue of $28.913 billion which increased to $30.117 billion in 2021, and further to $31.686 billion in 2022.

Increasing Gross Profit: Medtronic has seen a rise in its gross profit, from $19.489 billion in 2020 to $19.634 billion in 2021, and eventually $21.541 billion in 2022. This implies that the company is becoming more efficient in its manufacturing and supply chain activities, which is a good sign for potential investors.

Comments

Prediction Buy
Perf. (%) 6.62%
Target price 86.426
Change
Ends at 22.05.26

Medtronic plc (NYSE: MDT) had its price target lowered by analysts at Mizuho from $100.00 to $98.00. They now have an "outperform" rating on the stock.
Ratings data for MDT provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 6.62%
Target price 89.072
Change
Ends at 22.05.26

Medtronic plc (NYSE: MDT) had its price target lowered by analysts at Royal Bank of Canada from $105.00 to $101.00. They now have an "outperform" rating on the stock.
Ratings data for MDT provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 5.28%
Target price 100.500
Change
Ends at 21.02.26

I've got a good feeling about Medtronic! They're making some impressive moves in renewable energy and medical tech. That wind power deal in Ireland? Genius! It shows they're not just talking the sustainability talk, but walking the walk. Their financials look solid too, with decent cash flow and consistent dividend growth. The stock's been on a nice upswing lately, outperforming the broader market. Sure, there are challenges, but with their focus on innovation (like that new glucose monitoring system) and smart partnerships, I think they've got room to grow. The current price seems a bit undervalued compared to their potential. It's not without risks, but for a long-term play in healthcare, Medtronic could be just what the doctor ordered!
Show more

News

5 Things You Need to Know If You Buy Medtronic Today: https://g.foolcdn.com/editorial/images/821116/24_07_03-a-triangular-yellow-sign-that-says-high-yield-low-risk-on-it-_mf-dload-gettyimages-188027740-1200x800-5b2df79.jpg
5 Things You Need to Know If You Buy Medtronic Today

Medtronic (NYSE: MDT) is a large medical device maker, but its stock hasn't performed particularly well of late. After hitting a peak in 2021, the stock fell nearly 50% and has since moved roughly

Medtronic Just Announced a Move That Its Shareholders Should Love: https://g.foolcdn.com/editorial/images/820080/a-person-with-glucose-patch-on-their-arm.jpg
Medtronic Just Announced a Move That Its Shareholders Should Love

Medtronic (NYSE: MDT) is a medical device company with vast and diverse operations. Its business is fairly stable although the stock's returns haven't been all that great. However, it also provides

3 Stocks With 3% to 9% Yields Just Raised Dividends Again: https://www.marketbeat.com/logos/articles/med_20250602114807_3-stocks-with-3-to-9-yields-just-raised-dividends.png
3 Stocks With 3% to 9% Yields Just Raised Dividends Again

As firms continue releasing financial results late into the calendar Q1 earnings season, announcements of dividend increases also continue. Some of the latest announcements are particularly